Aigen Investment Management, LP Pfizer Inc Transaction History

Aigen Investment Management, LP

$440 Million
Q1 2024

A detailed history of Aigen Investment Management, LP transactions in Pfizer Inc stock. As of the latest transaction made, Aigen Investment Management, LP holds 94,301 shares of PFE stock, worth $2.64 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

94,301

Previous 30,109 213.2%

Holding current value

$2.64 Million

Previous $866,000 202.08%

% of portfolio

0.6%

Previous 0.16%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $1.66 Million - $1.91 Million	64,192 Added 213.2%	94,301 $2.62 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $786,748 - $1.02 Million	30,109 New	30,109 $866,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $14.1 Million - $18.4 Million	357,896 New	357,896 $14.6 Million
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $2.22 Million - $2.64 Million	47,789 New	47,789 $2.51 Million
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $4.8 Million - $5.95 Million	-104,900 Closed	0 $0

Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $4.33 Million - $6.43 Million	104,900 New	104,900 $6.03 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $8.52 Million - $10.9 Million	-217,104 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $7.8 Million - $8.83 Million	217,104 New	217,104 $8.5 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $2.83 Million - $3.59 Million	-84,437 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$31.75 - $37.25 $530,606 - $622,522	-16,712 Reduced 16.52%	84,437 $3.1 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $2.69 Million - $3.27 Million	89,368 Added 758.58%	101,149 $3.31 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $318,440 - $454,982	11,781 New	11,781 $385,000

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Account

Aigen Investment Management, LP Pfizer Inc Transaction History